Diagnostic imaging methods using rhenium and technetium complexe

Details Diagnostic imaging methods using rhenium and technetium complexe Diagnostic imaging methods using rhenium and technetium complexe

1995-06-06

1997-11-18

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

5483275, A61K 5104

Patent

active

056884877

ABSTRACT:
Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprising

REFERENCES:
patent: 3369121 (1968-02-01), Bruno et al.
patent: 3920995 (1975-11-01), Czaplinski et al.
patent: 4071613 (1978-01-01), Hunter, Jr.
patent: 4193979 (1980-03-01), Frank et al.
patent: 4272503 (1981-06-01), Camin et al.
patent: 4311689 (1982-01-01), Ruddock
patent: 4363793 (1982-12-01), Blau et al.
patent: 4431626 (1984-02-01), Henze
patent: 4444690 (1984-04-01), Fritzberg
patent: 4462992 (1984-07-01), Agrawal et al.
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4638051 (1987-01-01), Burns et al.
patent: 4758682 (1988-07-01), Collins et al.
patent: 4789736 (1988-12-01), Canning et al.
patent: 4818813 (1989-04-01), Nowotnik et al.
patent: 4849511 (1989-07-01), Verbruggen
patent: 4871836 (1989-10-01), Francescono et al.
patent: 4880616 (1989-11-01), Azuma et al.
patent: 4895960 (1990-01-01), Deutsch
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4980147 (1990-12-01), Fritzberg et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5026829 (1991-06-01), Deutsch
patent: 5037631 (1991-08-01), Nosco
patent: 5071636 (1991-12-01), Yamauchi et al.
patent: 5075099 (1991-12-01), Srinivasan et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5096693 (1992-03-01), Azuma et al.
patent: 5101041 (1992-03-01), Troutner et al.
patent: 5104638 (1992-04-01), Nosco
patent: 5116596 (1992-05-01), Bremer et al.
patent: 5116598 (1992-05-01), Nosco
patent: 5164175 (1992-11-01), Bremer et al.
patent: 5164176 (1992-11-01), Gustavson et al.
patent: 5187264 (1993-02-01), Verbruggen
patent: 5302370 (1994-04-01), Neumeier et al.
patent: 5387409 (1995-02-01), Nunn et al.
patent: 5387692 (1995-02-01), Riley et al.
patent: 5506345 (1996-04-01), Riley et al.
Chapman, J.D., "Measurement of Tumor Hypoxia by Invasive and Non-Invasive Procedures: A Review of Recent Clinical Studies", Radiother. Oncol., 20, pp. 13-19 (1991). H!Fluoromisonidazole in Ischemic Myocardium", J. Nucl. Med., vol. 30, No. 2, 194-201 (1989). in Cerebral Ischemia". Stroke, 18:168-176 (1987). Fluoromisonidazole", J.Nucl.Med., 30,789 (No. 252) (1989).
Biskupiak, J.E. et al., "Synthesis of an (Iodovinyl)misonidazole Derivative for Hypoxia Imaging", J. Med. Chem., 34, pp. 2165-2168 (1991).
Chapman, J.D., "The Detection and Measurement of Hypoxic Cells in Solid Tumors", Cancer, Vo. 54, No. 11, pp. 2441-2449 (1984).
Kedderis, G.L. et al, "The Metabolic Activation of Nitroheterocyclic Therapeutic Agents", Drug Metabolism Reviews, 19(1), pp. 33-62 (1988).
Adams, G.E. et al., "Hypoxia-Mediated Nitro-Heterocyclic Drugs in The Radio-and Chemothrapy of Cancer", Biochemical Pharmacology, vol. 35, No. 1, pp. 71-76 (1986).
Brown, D.M. et al., "Structure-Activity Reationships of 1-Substituted 2-Nitroimidazoles: Effect of Partition Coefficient and Side-chain Hydroxyl Groups on Radiosensitization In Vitro", Radiation Research, 90, pp. 98-108 (1982).
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. I. Sensitizatoin Efficiency", Int. J. Radiat. Biol., vol. 35, No. 2, pp. 133-150 (1979).
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. III. Effects of Basic Substituents in Nitromidazole Sidechains", Int. J. Radiat. Biol., vol. 38, No. 6, pp. 613-626 (1980).
Jerabek, P.A., et al., "Synthesis and Biodistribution of .sup.18 F-Labeld Fluoronitroimidazoles: Potential In Vivo Markers of Hypoxic Tissue", Appl. Radiat. Isot. vol. 37, No. 7, pp. 599-605 (1986).
Martin, G.V. et al, "Fluoromisonidazole A Metabolic Marker of Myocyte Hypoxia", Circulation Research, 67, pp. 240-244 (1990).
Shelton, M.E. et al., "In Vivo Delineation of Myocardial Hypoxia During Coronary Occlusion Using Fluorin-14 Fluoromisonidazole and Positron Emission Tomography: A Potential Approach for Idntification of Jeopardized Myocardium", J. Am. College Cardiology, vol. 16, No. 2, pp. 477-485 (Aug. 1990).
Mannan, R.H. et al., "Radioiodinated 1-(5-Iodo-5-deoxy-.beta.-D-arabinofuranosyl)-2-nitroimidazole (Iodazomycin Arabinoside: IAZA): A Novel Marker of Tissue Hypoxia", The Journal of Nuclear Medicine, vol. 32, No. 9, pp. 1764-1770 (1991).
Parker, D., "Harnessing the Kinetic Stability of Macrocyclic Complexes In Vivo," presented at the 16th Int. Symp. on Macrocyclic Chemistry, Univ. of Sheffield, UK (Sep. 1-6, 1991).
Yang, L. et al., "Synthesis of Metronidazole Derivative and Its Distribution in Sarcoma 180 Bearing Mice", J. of Medical Colleges of PLA; 2(3) pp. 265-269 (1987).
Volkert, W.A. et al., ".sup.99m Tc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical", Eur. J. Nucl. Med., 9, pp. 511-516 (1984).
Kung, H.F., et al., "Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier", The Journal of Nuclear Medicine, 25, pp. 326-332 (1984).
Lever, S.Z. et al., "Design, Preparation, and Biodistribution of a Technetium-99m Triaminedithiol Complex to Asess Regional Cerebral Blood Flow", J. Nucl. Med., 26, pp. 1287-1294 (1985).
Jurisson et al., "Synthesis, Characterization, and X-ray Structural Determination of Technetium (V)-Oxo-Tetradentate Amine Oxime Complexes", Inorg. Chm., 25, pp. 543-549 (1986).
Ding et al., "Review and Prospectives of Brain Radioppharmaceuticals", Nucl. Sci. J., 29(5), pp. 341-348 (1992).
Fattorusso et al., J. Chem. Soc., Daltons Trans., p. 752 (1970).
Moody et al., J. Chem. Soc. Perkin Trans. 1, (1), pp. 18-24 (1972).
Hook et al., Anti-Cancer Drug Res., 4(3), pp. 173-190 (1989).
Orna et al., "Correlation of Kinetic Parameters of Nitroreductase Enzymes with Redox Properties of Nitroaromatic Compounds", J. Biol. Chem., vol. 264, 21, pp. 12379-12384 (1989).
Murmann, K., "The Interaction of 2-Methyl-2-amino-3-butanone Oxime with Nickel (II) and Copper (II) Ions", J. Am. Chem. Soc., pp. 4174-4180 (1958).
Vassian et al., "Aromatization of an Aliphatic Amine Oxime Nickel (II) Complex by Molecular Oxygen", Inorg. Chemistry, vol. 6, No. 11, pp. 2043-2046 (1967).
Murmann et al., "An Unsymmetrical transDinitrocobalt (III) Complex. A Crystal Structure Determination", Inorg. Chem., vol. 12, No. 11, pp. 2625-2631 (1973).

Affiliated with

Also associated with

Rating

Diagnostic imaging methods using rhenium and technetium complexe does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic imaging methods using rhenium and technetium complexe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic imaging methods using rhenium and technetium complexe will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1563601